HF
GTBP icon

HRT Financial’s GT Biopharma GTBP Stock Holding History

HRT Financial’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52K Buy
+107,140
New +$43.5K ﹤0.01% 3766
2026
Q1 		– Sell
-11,767
Closed -$9K – 4155
2025
Q4 		$9K Buy
+11,767
New +$8.36K ﹤0.01% 3046
2024
Q1 		– Sell
-1,126
Closed -$8K – 2608
2023
Q4 		$8K Buy
+1,126
New +$8.23K ﹤0.01% 2096

Other funds holding GTBP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return
A
Alongside Austin, Texas $525M AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

HRT Financial's GTBP Position: Q2 2026 in Review

HRT Financial opened a new position in GT Biopharma (GTBP) in Q2 2026: 107,140 shares worth $52K. The stake represents ﹤0.01% of the portfolio and ranks #3766 among its holdings. This is a return to the name: HRT Financial previously reported a position in GTBP as recently as Q4 2025.

HRT Financial first reported a position in GTBP in Q4 2023 and has held it in 3 quarters since. 59 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • HRT Financial held 107,140 shares of GT Biopharma worth $52K as of Q2 2026.
  • GT Biopharma was a new HRT Financial position in Q2 2026.
  • GT Biopharma made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3766 holding.
  • HRT Financial first reported a position in GT Biopharma in Q4 2023 and has held it in 3 quarters since.
  • 59 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.